ReviewCriteria for the diagnosis of idiopathic pleuroparenchymal fibroelastosis: A proposal
Introduction
In 1992, Amitani et al. published a case series of 13 patients with a peculiar pulmonary fibrosis of unknown etiology that was localized in the bilateral upper lobes [1]. Based on imaging pattern characteristics, they named the fibrotic disease idiopathic pulmonary upper lobe fibrosis (IPUF). In the same paper, they presented 10 clinical, imaging, and histological characteristics of the condition: (1) constitutional slender stature with flattened thoracic cage; (2) chest radiograph findings of bilateral progressive fibrosis of the upper pulmonary lobes, with upward hilar retraction and volume loss in the upper lobes, but with few or no fibrotic opacities in the middle and lower lobes; (3) lesions in the subpleural areas with an apical cap-like appearance on chest radiograph; (4) appearance of multiple cysts in the lesions as the disease progresses, but without honeycombing; (5) frequent complication of recurrent and bilateral pneumothorax; (6) absence of extrathoracic lesions; (7) absence of acid-fast bacilli and no therapeutic effect of antituberculous drugs; (8) possible superimposed aspergillus infection; (9) slowly progressive condition and ultimately death within 10–20 years of presentation; (10) histological findings of non-specific fibrosis in the subpleural areas.
The Amitani et al. paper inspired Japanese investigators to publish several reports on IPUF itself [2], [3], [4], [5], [6], as well as on idiopathic upper lobe-dominant pulmonary fibrosis [7], [8], which is closely related to IPUF. In 2004, Frankel et al. described five patients with pulmonary fibrosis of unknown etiology. The patients predominantly showed bilateral involvement of the upper lobes, with pleural thickening. The investigators named the disorder idiopathic pleuroparenchymal fibroelastosis (IPPFE) after its histopathological characteristics, which differed from those of all previously described idiopathic interstitial pneumonias (IIPs) [9]. IPPFE, IPUF, and idiopathic upper-lobe-dominant pulmonary fibrosis overlap in terms of both histopathology and clinical features, but IPPFE is currently categorized by the American Thoracic Society and European Respiratory Society as a rare IIP [10]. Therefore, in the present paper, we have included both IPUF and idiopathic upper-lobe-dominant pulmonary fibrosis in the definition of IPPFE [11].
With this in mind, we propose diagnostic criteria for IPPFE in patients who have undergone surgical lung biopsy (SLB) and those who have not (Table 1, Table 2, Table 3, Table 4, Table 5). In practice, clinicians have limited opportunities to perform SLB in patients with suspected PPFE because such patients tend to have poor physiological and/or general condition, as well as an increased risk of postoperative complications liked prolonged pneumothorax [12]. Thus, researchers and clinicians must establish clinical diagnostic criteria for IPPFE in the absence of SLB.
The Medical Ethics Review Board of Fukuoka University approved the present study (#2018M70).
Section snippets
Diagnostic criteria for IPPFE in patients with SLB (Table 1)
We propose the following three criteria for the diagnosis of “definite IPPFE” in patients who have undergone SLB: (1) Multiple subpleural areas of airspace consolidation, with traction bronchiectasis located predominantly in the upper lobes, as visualized on high-resolution computed tomography (HRCT) scans (Fig. 1) [10], [13], [14], [15], [16]. (2) SLB findings of subpleural zonal or wedge-shaped dense fibrosis consisting of collapsed alveoli and collagen-filled alveoli with alveolar septal
Discussion
In the present manuscript, we have proposed diagnostic criteria for IPPFE both with and without SLB. IPPFE is not as rare as was previously considered [52]. However, clinicians still lack universally accepted criteria to diagnose the condition. Such criteria are urgently needed, especially in the case of patients from whom it is impossible to obtain biopsy samples.
Previous therapeutic trials involving IPPFE have all been single-center studies reporting either a single case or a small sample of
Conclusion
We have proposed criteria for the diagnosis of IPPFE with and without SLB. Because physicians have few opportunities to perform SLB in suspected IPPFE, criteria for the diagnosis of IPPFE that do not require SLB must be established. Physiological criteria, RV/TLC %pred. ≥115% and/or BMI ≤20 kg/m2 plus RV/TLC %pred. ≥80%, may successfully discriminate patients with IPPFE from those with chronic IIPs.
Role of the funding source
This study was partially supported by a grant from the Ministry of Health, Labour and Welfare of Japan, awarded to the Study Group on Diffuse Pulmonary Disorders, Scientific Research/Research on Intractable Diseases.
Conflicts of interest
The authors have no conflicts of interest for this article.
References (55)
- et al.
Idiopathic pleuroparenchymal fibroelastosis. Description of a novel clinicopathologic entity
Chest
(2004) - et al.
Rare idiopathic interstitial pneumonias (IIPs) and histologic patterns in new ATS/ERS multidisciplinary classification of the IIPs
Eur J Radiol
(2015) - et al.
Rapid decrease in forced vital capacity in patients with idiopathic pulmonary upper lobe fibrosis
Respir Investig
(2012) - et al.
Heterogeneous clinical features in patients with pulmonary fibrosis showing histology of pleuroparenchymal fibroelastosis
Respir Investig
(2016) - et al.
Functional associations of pleuroparenchymal fibroelastosis and emphyema with hypersensitivity pneumonitis
Respir Med
(2018) - et al.
Upper lobe fibrosis and cavitation in rheumatoid disease
Br J Dis Chest
(1980) - et al.
Massive bilateral upper lobe fibrosis secondary to asbestos exposure
Chest
(1974) Pleural and parenchymal fibrosis mainly affecting the upper lung lobes in persons exposed to asbestos
Respir Med
(1990)- et al.
Pleuroparenchymal fibroelastosis in patients with pulmonary disease secondary to bone marrow transplantation
Mod Pathol
(2011) - et al.
Restrictive allograft syndrome post lung transplantation is characterized by pleuroparenchymal fibroelstosis
Mod Pathol
(2013)
Pulmonary manifestations of ankylosing spondylitis
Clin Chest Med
Pleruroparenchymal fibroelastosis: distinct pulmonary physiological features in nine patients
Respir Investig
Distinct characteristics of pleuroparenchymal fibroelastosis with usual interstitial pneumonia compared with idiopathic pulmonary fibrosis
Chest
Pleuroparenchymal fibroelastosis diagnosed by multidisciplinary discussion in Japan
Respir Med
Clinical diagnosis of pleuroparenchymal fibroelastosis: a retrospective multicenter study
Respir Med
[Idiopathic pulmonary upper lobe fibrosis
Kokyu
Idiopathic pulmonary fibrosis of the upper lobe: a case report
Nihon Kokyuki Gakkai Zasshi
A case of so-called “idiopathic pulmonary upper lobe fibrosis” complicated by both mediastinal emphysema and bilateral pneumothorax at different times
Kokyu
A case of idiopathic pulmonary upper lobe fibrosis
Shindan Byori
A case of idiopathic pulmonary upper lobe fibrosis complicated by invasive pulmonary aspergillosis
Nihon Kokyuki Gakkai Zasshi
Pathology of idiopathic pulmonary upper lobe fibrosis
Nihon Kyobu Rinsho
Two cases of marked pulmonary fibrosis in the upper lung field
Kokyu
Seven cases of marked pulmonary fibrosis in the upper lobe
Nihon Kokyuki Gakkai Zasshi
Update of the international multidisciplinary consensus classification of the idiopathic interstitial pneumonias
Am J Respir Crit Care Med
Why does the pathological classification of IIPs vary among pathologists?
Intractable pneumothorax after video-assisted thoracoscopic lung biopsy in a case of pleuroparenchymal fibroelastosis with rheumatoid arthritis
J Jpn Soc Resp Endosc
Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes
Eur Respir J
Cited by (55)
Pulmonary fibroelastosis - A review
2023, Matrix BiologyComparative study of the two diagnostic criteria for idiopathic pleuroparenchymal fibroelastosis
2023, Respiratory Medicine and ResearchHome high-flow nasal therapy in a patient with pleuroparenchymal fibroelastosis: A case report
2023, Respiratory InvestigationVocal cord paralysis associated with pleuroparenchymal fibroelastosis: A case report and literature review
2023, Respiratory InvestigationPartial pressure of carbon dioxide levels reflect disease severity in idiopathic pleuroparenchymal fibroelastosis
2023, Respiratory Investigation